HCA Healthcare Inc. logo

HCA Healthcare Inc. (HCA)

Market Closed
24 Feb, 20:00
NYSE NYSE
$
526. 52
-9.45
-1.76%
$
119.03B Market Cap
13.35 P/E Ratio
0.55% Div Yield
1,234,722 Volume
18.19 Eps
$ 535.97
Previous Close
Day Range
522.58 536.15
Year Range
295 552.9
Want to track HCA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
HCA earnings report is expected in 57 days (23 Apr 2026)
HCA Healthcare raises annual profit forecast on strong demand for medical care

HCA Healthcare raises annual profit forecast on strong demand for medical care

HCA Healthcare raised its annual profit forecast on Tuesday, after beating Wall Street estimates for quarterly earnings, sending shares of the hospital operator up nearly 7% before the bell.

Reuters | 1 year ago
Is HCA Healthcare (HCA) Stock Outpacing Its Medical Peers This Year?

Is HCA Healthcare (HCA) Stock Outpacing Its Medical Peers This Year?

Here is how HCA Healthcare (HCA) and AnaptysBio, Inc. (ANAB) have performed compared to their sector so far this year.

Zacks | 1 year ago
HCA Healthcare Q2 Earnings Preview: Cost And Margin In Focus

HCA Healthcare Q2 Earnings Preview: Cost And Margin In Focus

HCA Healthcare, Inc. will report earnings on Tuesday, July 23rd. I expect HCA to have a strong quarter based on reaffirmed guidance, industry trends, and consensus revisions upward. Multiple valuation methods signal HCA is fairly priced, while industry trends suggest balanced upside and downside. I continue to rate HCA a hold.

Seekingalpha | 1 year ago
Can HCA Healthcare (HCA) Beat Q2 Earnings on Growing Admissions?

Can HCA Healthcare (HCA) Beat Q2 Earnings on Growing Admissions?

HCA Healthcare's (HCA) second-quarter earnings are likely to benefit from improved admissions and payer mix, partially offset by rising operating expenses.

Zacks | 1 year ago
HCA Healthcare (HCA) Reports Next Week: Wall Street Expects Earnings Growth

HCA Healthcare (HCA) Reports Next Week: Wall Street Expects Earnings Growth

HCA (HCA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
Got $1,000? 2 Incredible Growth Stocks to Buy and Hold Forever

Got $1,000? 2 Incredible Growth Stocks to Buy and Hold Forever

These healthcare businesses are booming. Vertex Pharmaceuticals is raking in approvals, cash, and profits.

Fool | 1 year ago
Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Zacks | 1 year ago
Will HCA (HCA) Beat Estimates Again in Its Next Earnings Report?

Will HCA (HCA) Beat Estimates Again in Its Next Earnings Report?

HCA (HCA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 1 year ago
Here's Why HCA Healthcare (HCA) is a Strong Value Stock

Here's Why HCA Healthcare (HCA) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch

Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.

Zacks | 1 year ago
Here's Why HCA Healthcare (HCA) is a Strong Momentum Stock

Here's Why HCA Healthcare (HCA) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
Compelling Reasons to Hold on to HCA Healthcare (HCA) Stock

Compelling Reasons to Hold on to HCA Healthcare (HCA) Stock

HCA Healthcare (HCA) remains well-poised for growth on the back of improved revenues, a well-diversified healthcare portfolio and solid cash-generating abilities.

Zacks | 1 year ago
Loading...
Load More